$3.23
+0.78%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$3.19
From 52W high−53.73%
Volume1.16M
Market cap$155.45M
P/E (TTM)—
P/S (TTM)0.8x
Div yield—
Key dataSep 18, 2026
Open
$3.19
From 52W high
−53.73%
Volume
1.16M
Market cap
$155.45M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−10.3x
P/E (TTM)
—
RSI (14)
47.8
MomentumView details →
1D Return
+0.78%
YTD Return
−4.99%
SummaryUpdated Jun 1, 2026
LifeMD, Inc. (NASDAQ:LFMD) is a direct-to-patient telehealth company founded in 1994 and headquartered in New York, New York. Originally known as Conversion Labs, Inc., the company rebranded to LifeMD in February 2021 to better reflect its evolution into a comprehensive virtual healthcare provider. The company has transformed from its early roots into a multi-brand telehealth platform that connects consumers directly to licensed healthcare professionals across various medical specialties. LifeMD went public in 2008 and has since expanded its offerings to include specialized telehealth brands, prescription medications, and digital health solutions, positioning itself as a leader in the rapidly growing direct-to-consumer healthcare market.
Similar companies
Latest newsMore news →
AT&T launched an exclusive collaboration with LifeMD to offer eligible AT&T wireless and fiber customers a complimentary LifeMD virtual care and pharmacy membership valued at $228 annually.5d agoLifeMD reported second quarter 2026 revenue of $47.3 million and an adjusted EBITDA loss of approximately $3.5 million, improving about 21% sequentially.46d ago